That’s the query posed by Buntin et al. (2022). The authors used information from the 2007-2018 Medicare Grasp Beneficiary Abstract File after which ran a regression adjustment to regulate for affected person demographics (i.e., age, intercourse), variety of continual circumstances (none, 1-3, ≥4), and whether or not the person had Half A or Components A and B protection.
Utilizing this strategy the authors discovered that:
Between 2008 to 2011 and 2012 to 2015, the adjusted annual Medicare Components A and B per-beneficiary spending development price declined from 3.3% to −0.1%. From 2016 to 2018, the imply annual Medicare spending development price rose relative to the earlier interval however remained decrease than within the baseline interval at 1.7% per 12 months. This slowdown prolonged throughout all sectors inside Components A and B, apart from physician-administered medication supplied beneath Half B. Modifications in cost charges (together with sequestration measures) and beneficiary traits defined 44% of the distinction in general per-beneficiary spending development between 2007 to 2011 and 2012 to 2015, and 63% between 2007 to 2011 and 2016 to 2018.
The authors discover that the majority cost charges tracked pretty near inflation (21.0% over this time interval), however doctor reimbursement solely elevated by 6.5%.
The authors notice that their findings are in keeping with the Congressional Price range Workplace’s discovering that general extra price development—or per capita spending development above and past per capita GDP development —in Medicare between 2005 and 2017 was −0.1%. In different phrases, Medicare spending was 0.1 share factors decrease than financial development over this time interval.